Post marketing experiences with erenumab (Aimovig) for the treatment of chronic migraine in a reallife clinical setting

Zyloney, C; Barker, C; Yu, YD; Villanueva, R; Schwarz, H

NEUROLOGY, 2020; 94 (15):